Table 5.
Results for Subset 2.
| Participant group | n | Pretreatment/baseline |
Posttreatment/follow-up |
||
|---|---|---|---|---|---|
| Group mean (SD) | Min–Max | Group mean (SD) | Min–Max | ||
| All patients (pooled) | 25 | 29.1 (18.6) | 0.4–65.7 | 15.9 (14.8) | 0.0–50.6 |
| PVH | 21 | 28.1 (19.3) | 0.4–65.7 | 16.6 (15.1) | 0.0–50.6 |
| NPVH | 4 | 33.8 (15.7) | 12.2–49.1 | 11.8 (13.6) | 0.0–30.4 |
| Controls | 10 | 1.3 (2.4) | 0.0–7.5 | 1.8 (3.5) | 0.0–11.3 |
Note. Group mean, standard deviation, minimum (Min), and maximum (Max) of the weeklong average of vocal effort scores for participants during their first week of voice monitoring (pretreatment for patients and baseline for controls) and second week (posttreatment for patients and follow-up by at least 6 months for individuals in the control group). Results for all patients with vocal hyperfunction are shown pooled (as statistically analyzed) and by diagnosis (phonotraumatic vocal hyperfunction [PVH] or nonphonotraumatic vocal hyperfunction [NPVH]).